AU2002361168B2 - Cytotoxic cyplasin of the sea hare, Aplysia punctata, cDNA cloning and expression of bioreactive recombinants - Google Patents

Cytotoxic cyplasin of the sea hare, Aplysia punctata, cDNA cloning and expression of bioreactive recombinants Download PDF

Info

Publication number
AU2002361168B2
AU2002361168B2 AU2002361168A AU2002361168A AU2002361168B2 AU 2002361168 B2 AU2002361168 B2 AU 2002361168B2 AU 2002361168 A AU2002361168 A AU 2002361168A AU 2002361168 A AU2002361168 A AU 2002361168A AU 2002361168 B2 AU2002361168 B2 AU 2002361168B2
Authority
AU
Australia
Prior art keywords
cyplasin
cells
nucleic acid
protein
acid molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2002361168A
Other languages
English (en)
Other versions
AU2002361168A1 (en
Inventor
Christian Petzelt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioxen Ltd
Original Assignee
Bioxen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioxen Ltd filed Critical Bioxen Ltd
Publication of AU2002361168A1 publication Critical patent/AU2002361168A1/en
Assigned to CYPLASIN BIOMEDICAL, LTD. reassignment CYPLASIN BIOMEDICAL, LTD. Request for Assignment Assignors: PETZELT, CHRISTIAN
Application granted granted Critical
Publication of AU2002361168B2 publication Critical patent/AU2002361168B2/en
Assigned to BIOXEN LTD. reassignment BIOXEN LTD. Request for Assignment Assignors: CYPLASIN BIOMEDICAL, LTD.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y10S530/857—Fish; fish eggs; shell fish; crustacea

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002361168A 2002-01-07 2002-12-18 Cytotoxic cyplasin of the sea hare, Aplysia punctata, cDNA cloning and expression of bioreactive recombinants Ceased AU2002361168B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP02000388 2002-01-07
EP02000388.5 2002-01-07
EP02019914.7 2002-09-04
EP02019914A EP1325929B1 (en) 2002-01-07 2002-09-04 Cytotoxic cyplasin of the sea hare, Aplysia punctata, cDNA cloning and expression of bioreactive recombinants
PCT/EP2002/014511 WO2003057726A1 (en) 2002-01-07 2002-12-18 Cytotoxic cyplasin of the sea hare, Aplysia punctata, cDNA cloning and expression of bioreactive recombinants

Publications (2)

Publication Number Publication Date
AU2002361168A1 AU2002361168A1 (en) 2003-07-24
AU2002361168B2 true AU2002361168B2 (en) 2008-05-08

Family

ID=26077563

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002361168A Ceased AU2002361168B2 (en) 2002-01-07 2002-12-18 Cytotoxic cyplasin of the sea hare, Aplysia punctata, cDNA cloning and expression of bioreactive recombinants

Country Status (7)

Country Link
US (1) US7271242B2 (enExample)
EP (1) EP1325929B1 (enExample)
JP (1) JP2005527194A (enExample)
CN (1) CN1622956A (enExample)
AU (1) AU2002361168B2 (enExample)
CA (1) CA2472280C (enExample)
WO (1) WO2003057726A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7407784B2 (en) * 2003-01-20 2008-08-05 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. L-amino acid oxidase with cytotoxic activity from Aplysia punctata
US7482157B2 (en) 2003-12-24 2009-01-27 Food Industry Research & Development Institute Monacolin K biosynthesis genes
CN106868198B (zh) * 2017-04-25 2020-09-18 扬州宏盛水产科技有限公司 一种同时检测鲇形目鱼类四种致病菌的多重pcr引物组及监测方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Keifer, P. et al. (1994) EMBO Journal 13(17): 4126-4136 *
Sturley, S.L. et al. (1994) J. of Biol. Chem. 269(34): 21670-21675 *

Also Published As

Publication number Publication date
CA2472280A1 (en) 2003-07-17
EP1325929A3 (en) 2003-07-16
WO2003057726A1 (en) 2003-07-17
CA2472280C (en) 2010-04-13
US7271242B2 (en) 2007-09-18
AU2002361168A1 (en) 2003-07-24
US20050277763A1 (en) 2005-12-15
EP1325929B1 (en) 2009-03-25
JP2005527194A (ja) 2005-09-15
CN1622956A (zh) 2005-06-01
EP1325929A2 (en) 2003-07-09

Similar Documents

Publication Publication Date Title
JP4411330B2 (ja) 腫瘍壊死因子関連リガンド
EP0775711B1 (en) Peptide having antithrombotic activity and process for producing the same
KR100397244B1 (ko) 거핵구분화인자
Jung et al. Purification and cloning of an apoptosis-inducing protein derived from fish infected with Anisakis simplex, a causative nematode of human anisakiasis
JP2002521055A (ja) ９８個のヒト分泌タンパク質
KR20010015711A (ko) 폴리펩티드, 그 폴리펩티드를 암호화하는 ｃＤＮＡ 및그들의 용도
CA2181062A1 (en) Diagnosis of metastatic cancer by the mts-1 gene
WO1993025685A1 (en) Cloning and characterization of the cell death genes ced-3 and ced-4
US6607897B2 (en) Recombinant proCVF
KR20010031991A (ko) 인간 리조포스파티딘산 수용체 물질 및 그 용도
US6368845B1 (en) Polypeptides having L-asparaginase activity
CA2472280C (en) Cytotoxic cyplasin of the sea hare, aplysia punctata, cdna cloning and expression of bioreactive recombinants
Petzelt et al. Cytotoxic cyplasin of the sea hare, Aplysia punctata, cDNA cloning, and expression of bioactive recombinants in insect cells
Harafuji et al. Enhancement of foot formation in Hydra by a novel epitheliopeptide, Hym-323
US5856444A (en) Thrombocytopoiesis stimulating factor
CN110194800B (zh) 一种融合蛋白、细胞外泌体和肿瘤疫苗及其应用
JP2003517311A (ja) カスパーゼにより誘導されるアポトーシスのための組成物および方法
HK1058678A (en) Cytotoxic cyplasin of the sea hare, aplysia punctata, cdna cloning and expression of bioreactive recombinants
Gottsch et al. Cloning and sequence analysis of human and bovine corneal antigen (CO-Ag) cDNA: identification of host-parasite protein calgranulin C
HIRANO et al. Cloning and functional expression of a degradation-resistant novel isoform of p27Kip1
JP3819540B2 (ja) Ｌ−アスパラギナーゼ活性を有する哺乳類由来のポリペプチド
HK1077584A (en) Cytotoxic cyplasin of the sea hare, aplysia punctata, cdna cloning and expression of the bioreactive recombinants
US6147052A (en) Method of differentiating erythrocyte progenitor cells
EP2140000A1 (en) Method of enhancing migration of neural precursor cells
WO1997000951A1 (fr) Adn codant pour un inhibiteur du complement, d'origine porcine

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: CYPLASIN BIOMEDICAL, LTD.

Free format text: FORMER APPLICANT(S): PETZELT, CHRISTIAN

FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: BIOXEN LTD.

Free format text: FORMER OWNER WAS: CYPLASIN BIOMEDICAL, LTD.

MK14 Patent ceased section 143(a) (annual fees not paid) or expired